Rituxan®
What is Rituxan®?
Rituxan® (rituximab) is a monoclonal antibody used to treat autoimmune diseases and certain types of blood cancers by targeting CD20, a protein found on B-cells. By binding to CD20, Rituxan® helps the immune system identify and remove these cells, reducing inflammation and abnormal immune responses in autoimmune conditions, while also depleting cancerous B-cells in blood cancers.
How much does Rituxan® cost?
Rituxan® cost can vary depending on several factors including insurance status and provider. Our team at Rocky Mountain MS Clinic is dedicated to helping patients access treatment affordably and easily.
We work with most leading commercial insurance providers across the Rocky Mountain region, including Aetna, Anthem, Blue Cross Blue Shield, Cigna, Humana, and UnitedHealthcare, as well as Medicaid and Medicare.
We handle prior authorizations, benefits verification, and will guide you through copay and foundation support programs to help reduce your out-of-pocket expenses.
How does Rituxan® work?
Rituxan® targets and eliminates B-cells that carry the CD20 protein, which play a role in autoimmune disease activity and blood cancers. By reducing these overactive B-cells, Rituxan® helps calm the immune system, decrease inflammation, and slow disease progression while improving symptoms.
Why Patients Choose Rocky Mountain Infusion Center to Receive Their Rituxan® Infusion:
Clinical Excellence and Neurological Expertise
Our infusion center is led by board-certified neurologists and supported by BSN-prepared and Multiple Sclerosis-certified Registered Nurses who specialize in infusion care for neurological conditions.
Lower Costs and Financial Assistance
We coordinate all insurance approvals and provide hands-on help with copay assistance and financial support programs.
A Cigna report found that patients receiving care in physician-owned infusion sites, like Rocky Mountain MS Clinic’s Infusion Center, experience significantly lower out-of-pocket and overall costs compared to hospital outpatient centers.
Established leader in MS & Neurological care
Over 35+ years serving individuals with MS and other neurological conditions across the Intermountain region.
The infusion clinic nurses are highly trained in Neurological conditions, personable, professional and careful. Having a doctor and team like this on your side of the fight against MS is invaluable.
They are constantly improving their in-house infusion center to ensure the comfort of their patients. The team there is professional and highly trained!
As someone who frequents their infusion center on a monthly basis, I can confidently say that it's top-notch. The staff at the infusion center are amazing, providing not only excellent medical care but also creating a comfortable and soothing environment for patients. Their dedication to patient comfort and well-being is evident in every aspect of the center.
Important Info
Non-Hodgkin’s Lymphoma (NHL)
B-cell acute leukemia (B-AL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid arthritis (RA)
Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis)
Microscopic Polyangiitis (MPA)
Pemphigus Vulgaris (PV)
Non-Hodgkin’s Lymphoma (NHL): Approved on November 26, 1997
B-cell acute leukemia (B-AL): Approved on February 10, 2006
Chronic Lymphocytic Leukemia (CLL): Approved on February 19, 2010
Rheumatoid arthritis (RA): Approved on February 28, 2006
Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis): Approved on September 27, 2019
Microscopic Polyangiitis (MPA): Approved on September 27, 2019
Pemphigus Vulgaris (PV): Approved on June 7, 2018
Genentech